PUBLISHER: The Insight Partners | PRODUCT CODE: 1871468
PUBLISHER: The Insight Partners | PRODUCT CODE: 1871468
The South and Central America positive airway pressure (PAP) devices market is projected to grow significantly, reaching an estimated US$ 563.53 million by 2031, up from US$ 406.05 million in 2023, reflecting a compound annual growth rate (CAGR) of 4.2% from 2023 to 2031.
Executive Summary and Market Analysis
The PAP devices market in South and Central America is divided into key regions: Brazil, Argentina, and the Rest of South and Central America. The anticipated growth in this market is driven by advancements in healthcare infrastructure and facilities across the region. Furthermore, the increasing adoption of innovative PAP products is expected to further stimulate market expansion in the coming years.
Market Segmentation Analysis
The South and Central America PAP devices market can be analyzed through various segments, including product type, application, and end user.
Market Outlook
Traditionally, the management of sleep apnea involved CPAP machines, lifestyle changes, and surgical interventions. However, recent technological advancements are revolutionizing the diagnosis and treatment of sleep apnea, making management more convenient and effective. Innovations in diagnostic tools and treatment devices, along with remote monitoring capabilities, are enhancing the quality of life for individuals suffering from sleep apnea.
For instance, the SleepStyle CPAP device features an integrated humidifier and a user-friendly interface, along with a smartphone app for monitoring compliance and Bluetooth connectivity. Similarly, the Somnetics Transcend 3 Mini CPAP is designed for travel, incorporating advanced noise-canceling technology and intelligent pressure adjustments. Additionally, NovaResp Technologies Inc. is developing an AI-enabled CPAP algorithm that can predict apnea episodes, which can be integrated with various CPAP devices.
These technological innovations are not only expanding the market but also providing companies with a competitive advantage in managing respiratory conditions, particularly sleep apnea, leading to higher adoption rates.
Country Insights
The South and Central America PAP devices market is primarily represented by Brazil, Argentina, and the Rest of South and Central America, with Brazil holding the largest market share in 2023. Brazil boasts a robust medical device industry regulated by the Brazilian National Health Surveillance Agency (ANVISA), which ensures the safe use of medical devices, including PAP devices. The National Institute of Metrology, Standardization, and Industrial Quality (INMETRO) also plays a crucial role in setting industry standards.
According to the Pan American Health Organization, Brazil had over 30 million individuals aged 60 and above as of December 2022, representing 13% of the population. This demographic is projected to grow to approximately 50 million by 2030, constituting 24% of the population. The increasing number of elderly individuals, who are more prone to sleep disorders, is expected to drive the demand for PAP devices in Brazil in the coming years.
Company Profiles
Key players in the PAP devices market include ICU Medical Inc., React Health (formerly 3B Medical, Inc.), Fisher & Paykel Healthcare Corp Ltd, BPL Medical Technologies Pvt Ltd, Koninklijke Philips NV, Dragerwerk AG & Co KGaA, ResMed Inc., Vyaire Medical Inc., Wellell Inc., Armstrong Medical Ltd, Lowenstein Medical UK Ltd., BMC Medical Co Ltd, and Narang Medical Limited, among others. These companies are pursuing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their product offerings and increase market share.